Thymosin ?-4 and Venous Ulcers
The objective of this double-blind, placebo-controlled, dose-escalation study is to evaluate safety, tolerability, and enhancement on healing of thymosin ?-4 (T?-4) administered topically in patients with venous ulcers. Three groups of patients, coming from 10 sites, 5 from Italy and 5 from Poland, will be enrolled sequentially. Twenty-four patients within each group will be randomized to T?-4 or placebo in a
thymosin ?-4 venous ulcers wound healing